KATRINA DOMINGO: Open Payments
NPI 1386463677 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $209 |
| Lilly USA, LLC | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Smith+Nephew, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
Products named: AIRSUPRA, MOUNJARO, REXULTI, JARDIANCE, COLLAGENASE SANTYL, TRELEGY ELLIPTA, AUSTEDO XR, FARXIGA.
Industry payments across CA — which companies pay providers there.
